Sophia Zoungas's Publications

Zoungas Sophia, Lo Clement, Walker Rowan, Zimbudzi Edward, Ranasinha Sanjeeva, Kerr Peter, Polkinghorne Kevan, Russell Grant, Fulcher Gregory, Jan Stephen
Factors associated with patient activation in an Australian population with comorbid diabetes and chronic kidney disease: a cross-sectional study.
Journal Article
2017
BMJ Open
Zoungas Sophia, Villani Melanie, Earnest Arul, Nanayakkara Natalie, Smith Karen, Ranasinha Sanjeeva, Teede Helena, Soldatos Georgia
Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational study.
Journal Article
2017
PLoS One
Cass Alan, Badve Sunil, Zoungas Sophia, Lo Clement, Jun Min, Pilmore Helen, White Sarah, Hawley Carmel, Perkovic Vlado
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Journal Article
2017
Cochrane Database Syst Rev
Zoungas S., Woodward Mark, Visseren F., Poulter N., Grobbee D., Mancia G., Harrap S., Heller S., Marre M., van der Leeuw J.
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
Journal Article
2016
Diabetologia
Zoungas S., Hirakawa Y., Lisheng L., Woodward Mark, Arima H., Poulter N., Williams B., Hamet P., Mancia G., Harrap S.
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes
Journal Article
2016
Journal of Hypertension
Zoungas S., Cooper M., Woodward Mark, Wong M., Matthews D., Poulter N., Williams B., Hamet P., Mancia G., Harrap S.
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Journal Article
2016
Diabetes Care
Zoungas S., Wong G., Poulter N., Kingwell B., Sullivan D., Woodward Mark, Nestel P., Williams B., Hillis G., Marre M.
Plasma Lipidomic Profiles Improve Upon Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes
Journal Article
2016
Circulation
Zoungas S., Smith K., Teede H., Ranasinha S., Villani M., Nanayakkara N., Tan C., Morgans A., Soldatos G.
Utilisation of emergency medical services for severe hypoglycaemia: An unrecognised health care burden
Journal Article
2016
Journal of Diabetes and Its Complications
Zoungas S., Kengne A., Hirakawa Y., Woodward Mark, Grobbee R., Poulter N., Cooper M., Jardine M, Matthews D., Chalmers J.
Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score
Journal Article
2016
Diabetes, Obesity & Metabolism
Zoungas S., Kerr P., Fulcher G., Teede H., Lo C., Walker R., Usherwood T., Gallagher M., Ranasinha S., Russell G.
Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease
Journal Article
2016
PLoS One
Zoungas S., Hirakawa Y., Lisheng L., Woodward Mark, Williams B., Mancia G., Harrap S., Marre M., Rodgers A, Mohammedi K.
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes
Journal Article
2016
Diabetes Care
Zoungas S., Teede H., Lo C., Usherwood T., Ranasinha S., Ilic D., Murphy K., Russell G.
Identifying health service barriers in the management of co-morbid diabetes and chronic kidney disease in primary care: a mixed-methods exploration
Journal Article
2016
Family Practice
Zoungas S., Huxley R., Woodward Mark, Blomster J., Poulter N., Mancia G., Harrap S., Hillis G., Chalmers J., Neal Bruce
The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
Journal Article
2016
BMJ Open
Zoungas S., Kerr P., Lo C., Usherwood T., Cass A., Ranasinha S., Zimbudzi E., Fulcher G.
Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL
Journal Article
2016
Journal of Diabetes and Its Complications
Zoungas S., Hirakawa Y., Woodward Mark, Poulter N., Colagiuri S., Hamet P., Harrap S., Marre M., Matthews D., Mohammedi K.
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
Journal Article
2016
Cardiovascular Diabetology
Zoungas S., Navaneethan S., Kang A., Nigwekar S., Kulshrestha S., Strippoli G., Cass A., Gallagher M., Jardine M, Perkovic Vlado
Interventions for lowering plasma homocysteine levels in dialysis patients
Journal Article
2016
Cochrane Database of Systematic Reviews
Zoungas S., Kerr P., Fulcher G., Teede H., Lo C., Mathew T., Polkinghorne K., Walker R., Cass A., Gallagher M.
The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study
Journal Article
2016
PLoS One
Zoungas S., Woodward Mark, Harrap S., Li Q., Marre M., Mohammedi K., Chalmers J., Patel Anushka
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes
Journal Article
2016
Diabetes Care
Zoungas S., Kerr P., Fulcher G., Teede H., Lo C., Polkinghorne K., Walker R., Usherwood T., Gallagher M., Ilic D.
Primary and tertiary health professionals' views on the health-care of patients with co-morbid diabetes and chronic kidney disease - a qualitative study
Journal Article
2016
BMC Nephrology
Zoungas S., Cooper M., Woodward Mark, Williams B., Hillis G., Li Q., Marre M., Thomas M., Pickering R., Chalmers J.
Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes
Journal Article
2015
Diabetes Care

Sophia Zoungas's Publications

Factors associated with patient activation in an Australian population with comorbid diabetes and chronic kidney disease: a cross-sectional study.

Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational study.

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON

Plasma Lipidomic Profiles Improve Upon Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes

Utilisation of emergency medical services for severe hypoglycaemia: An unrecognised health care burden

Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score

Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease

Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes

Identifying health service barriers in the management of co-morbid diabetes and chronic kidney disease in primary care: a mixed-methods exploration

The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial

Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study

Interventions for lowering plasma homocysteine levels in dialysis patients

The Perspectives of Patients on Health-Care for Co-Morbid Diabetes and Chronic Kidney Disease: A Qualitative Study

Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes

Primary and tertiary health professionals' views on the health-care of patients with co-morbid diabetes and chronic kidney disease - a qualitative study

Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country